{
    "clinical_study": {
        "@rank": "65495", 
        "arm_group": [
            {
                "arm_group_label": "Prostate Cancer Patients", 
                "description": "Prostate cancer patients who underwent radiation therapy"
            }, 
            {
                "arm_group_label": "Healthy control", 
                "description": "age-matched male who has no known prostate cancer"
            }
        ], 
        "biospec_descr": {
            "textblock": "Specimen:For future Research   Optional  Destruction if requested  identifiable Urine\n             yes\t       no\t             yes\t     no Sputum\t              yes\t       no\n       yes\t     no Blood\t              yes\t       no\t             yes\t     no"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "Prostate cancer is a common disease in men treated using surgery, radiation therapy and/or\n      hormonal therapy. Clinical prognosis relates to stage and grade of disease. Recent advances\n      in omic analysis may offer additional information to the physician about prognosis and\n      radiation response. We propose to establish a protocol to incorporate omic analysis into the\n      evaluation and treatment of patients with prostate cancer."
        }, 
        "brief_title": "Prostate Metabolomic Study", 
        "condition": "Prostate Cancer", 
        "condition_browse": {
            "mesh_term": "Prostatic Neoplasms"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Males who are older than 18 years old,\n\n          -  with clinically localized prostate cancer\n\n          -  are receiving radiation therapy\n\n        Exclusion Criteria:\n\n          -  none"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "200 prostate cancer patients vs. 200 healthy men"
            }
        }, 
        "enrollment": {
            "#text": "400", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 19, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01968538", 
            "org_study_id": "2009-096"
        }, 
        "intervention": {
            "arm_group_label": "Prostate Cancer Patients", 
            "intervention_name": "Radiation Therapy", 
            "intervention_type": "Radiation", 
            "other_name": "Prostate stereotactic body radiation therapy (SBRT) and intensive modulated radiation therapy (IMRT) or the combination of both (boost)"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 27, 2014", 
        "location": {
            "contact": {
                "email": "lnc@georgetown.edu", 
                "last_name": "Leonard N Chen, MD,PhD", 
                "phone": "202-444-3068"
            }, 
            "facility": {
                "address": {
                    "city": "Washington", 
                    "country": "United States", 
                    "state": "District of Columbia", 
                    "zip": "20007"
                }, 
                "name": "Georgetown University Hospital"
            }, 
            "investigator": {
                "last_name": "Sean P Collins, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "2", 
        "official_title": "A Pilot Study to Establish a Standardized Protocol for Omic Analysis of Patients With Clinically Localized Prostate Cancer Receiving Radiation Therapy", 
        "overall_contact": {
            "email": "lnc@georgetown.edu", 
            "last_name": "Leonard N Chen, MD,PhD", 
            "phone": "202-444-3068"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "molecular changes in biofluid", 
            "safety_issue": "No", 
            "time_frame": "5 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01968538"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Georgetown University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Georgetown University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2009", 
        "study_design": "Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "May 2014"
    }
}